Cargando…
Successful febuxostat desensitization in a patient with febuxostat hypersensitivity: A Malaysian experience
Over the years, allopurinol has been widely used as the preferred choice of urate lowering therapy in patients with gout. However, its role in patients with renal impairment is limited; and adverse reactions are well documented. Febuxostat, a newer oral non-purine xanthine oxidase inhibitor has been...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753890/ https://www.ncbi.nlm.nih.gov/pubmed/29318019 http://dx.doi.org/10.1177/2050313X17749080 |